Experimental models of multiple sclerosis

Cannabinoids and experimental models of

Cannabinoids and experimental models of multiple sclerosis

✍ Ilona Kubajewska; Cris S. Constantinescu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Experimental Models of Multiple Sclerosi

Experimental Models of Multiple Sclerosis || Induction of EAE

✍ Lavi, Ehud; Constantinescu, Cris S. 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 605 KB

Multiple Sclerosis (MS) is an enigmatic immune mediated disease of the central nervous system that affects about 350,000 individuals in the US, and many more around the world. The mechanism of this disease is largely unknown and there is no cure for it. However, there are several well-characterized

Pathogenic mechanisms and experimental m

Pathogenic mechanisms and experimental models of multiple sclerosis

✍ Slavin, Anthony; Kelly-Modis, Louise; Labadia, Mark; Ryan, Kelli; Brown, Maryann 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 164 KB

Axon Reactions Precede Demyelination in

Axon Reactions Precede Demyelination in Experimental Models of Multiple Sclerosis

✍ É. Zapryanova; O.S. Sotnikov; S.S. Sergeeva; D. Deleva; A. Filchev; B. Sultanov 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 410 KB

Current Gene-Mapping Strategies in Exper

Current Gene-Mapping Strategies in Experimental Models of Multiple Sclerosis

✍ K. Becanovic; M. Jagodic; E. Wallström; T. Olsson 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

Experimental Models of Multiple Sclerosi

Experimental Models of Multiple Sclerosis || EAE: History, Clinical Signs, and Disease Course

✍ Lavi, Ehud; Constantinescu, Cris S. 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 549 KB

Multiple Sclerosis (MS) is an enigmatic immune mediated disease of the central nervous system that affects about 350,000 individuals in the US, and many more around the world. The mechanism of this disease is largely unknown and there is no cure for it. However, there are several well-characterized